# PS-341 in Treating Patients With Advanced Cancer

> **NCT00006362** · PHASE1 · COMPLETED · sponsor: **Mayo Clinic**

## Conditions studied

- Leukemia
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
- Precancerous Condition
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** bortezomib

## Key facts

- **NCT ID:** NCT00006362
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-11
- **Primary completion:** 2003-08
- **Final completion:** 2003-08
- **Target enrollment:** — (—)
- **Last updated:** 2011-08-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006362, "PS-341 in Treating Patients With Advanced Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00006362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*